Literature DB >> 1831463

Cytotoxic and suppressor activities in patients with HTLV-I-associated myelopathy.

K Usuku1, M Nishizawa, M Osame, T Tabira.   

Abstract

Since there are several immune abnormalities and autoimmune-like features in human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/HTLV-I-associated tropical spastic paraparesis (HAM/TSP), we examined cytotoxic and suppressor cell functions in HAM/TSP. In this study, we assayed cell-mediated cytotoxicity of CD8+ T-cell lines established from cerebrospinal fluid lymphocytes of two patients with HAM and concanavalin A-induced suppressor cell activities of peripheral blood lymphocytes from five patients with HAM. Our study revealed that three of four CD8+ T-cell lines showed cytotoxic activities against autologous CD4+ T-cell lines infected with HTLV-I, and two of the three lines showed major histocompatibility complex class I-restricted cytotoxicity. We also demonstrated that the concanavalin A-induced suppressor function was not defective in HAM patients. Therefore, the immune abnormalities and autoimmune-like features observed in HAM/TSP may not result from defective cytotoxic or suppressor cell activities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831463     DOI: 10.1016/0165-5728(91)90107-i

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

Review 1.  Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).

Authors:  J M Johnson; R Harrod; G Franchini
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

2.  Suppression of lymphocyte spontaneous proliferative response by proteolipid protein peptide in patients with HAM/TSP.

Authors:  T Tabira; J Inobe; K Nakahara; M Osame; T Yamamura
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.